Pediatric heat-related illness emergency department volume is associated with higher temperatures and is increasing over time.

For infants and young children hospitalized with RSV infection, ziresovir reduces signs and symptoms of bronchiolitis.

In children developing asthma, levels of the immune mediator IL-10 are lower than normal by the time these children are 6 years of age.

The Food and Administration (FDA) has approved Otulfi (ustekinumab-aauz), a biosimilar to Stelara® (ustekinumab).

Supplemental allergy patch testing in patients with suspected ACD revealed allergens not detected in standard screening.

The 20-year cumulative incidence of keratinocyte carcinoma was 1.5% in those who survived childhood cancer, with most patients having several lesions.

Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

Consensus recommendations have been established for pediatric mycosis fungoides, including additional clinical severity and outcome measures.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

The United States government is offering another round of free COVID-19 tests, which will be available by the end of September.

Extreme temperature-related deaths are projected to increase considerably by the mid-21st century in the contiguous United States.

Fructose, carbonated soft drinks, and free sugar consumption may be linked to asthma, allergic rhinitis, and food allergies in children.